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1. Introduction 
Radioimmunoassay (RIA) has proved to be a highly 
successful analytical method, but is not without dis- 
advantages. The obligatory physical seperation of 
antibody-bound and free fractions of labelled antigen 
or hapten is a practical inconvenience and potential 
source of imprecision. Radiolabelled materials are 
often costly, may have limited shelf-life, present a 
radiation hazard, and necessitate expensive counting 
equipment. Non-isotopic labelling techniques which 
can obviate many or all of these shortcomings have 
accordingly received much attention, which has been 
largely focussed on enzyme immunoassay methods 
[ 1,2]. However, fluorescent-labelling also merits 
consideration when the extreme sensitivity of RIA is 
not called for. Fluoroimmunoassay methods based on 
detection of the extent of antibody binding of 
fluorescent-labelfed hapten in unseparated immuno- 
assay incubation mixtures by measurements of fluor- 
escence polarisation (polarisation fluoroimmunoassay) 
or fluorescence quenching (quenching fluoroimmuno- 
assay) have recently been applied to assay of genta- 
micin in serum [3,4]. 
The present report describes the preparation of a 
fluorescent derivative of thyroxine (T4) whose fluor- 
escence is enhanced when bound by anti-T4 serum, and 
illustratas in principle the exploitation of the effect 
in an ‘enhancement fluoroimmunoassay’ of T+ 
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2. Experimental 
Fluorescein-labelled T4 was prepared by reaction 
of 1 vol. 20 g/l (5 1.4 mM) fluorescein isothiocyanate 
(FITC) (isomer I; Sigma) with 2 vof. 20 g/l (25.7 mM) 
CT4 (free acid; Sigma) in a pyridine/water/triethyl- 
amine medium of composition 9 : 1.5 : 0.1 v/v/v. 
Reaction was complete after 1 h at room temperature 
(paper chromatography). Crude products were then 
precipitated with 20 vol. 0.2 M ammonium acetate 
buffer, pH 4.0, and collected by centrifugation (10 min, 
1 000 X g). The supernatant was discarded and the 
precipitate washed by suspension in 20 vol. distilled 
water followed by centrifugation as before. The 
product was redissolved in 4-8 vol. 0.05 M WHCOs 
with the aid, if necessary, of a minimal amount of 
ammonia solution. Aliquots (0.5 ml) were applied to 
small (0.9 X 4.5 cm) columns of Sephadex G-25 fine 
grade equilibrated with 0.05 M NH&ICOs. The labelled 
T4-product became adsorbed to the Sephadex-gel, 
allowing removal of small amounts of fluorescent 
impurities by passage of 10 column volumes of 0.05 M 
NI&HCOs. The purified product was then eluted from 
the columns with distilled water and either stored 
frozen (-18°C) or freeze-dried to a yellow/orange 
powder, stored desiccated at 4°C. 
Progress of reaction was monitored, and purity of 
products assessed, by chromatography on Whatman 
No. 1 paper developed with 0.2 M Na2HP04. Fluor- 
escein fluorophores were visualised under short-wave 
ultraviolet light, and the iodothyronine function of 
T4 with a diazotised sulphanilic acid spray (Pauly 
reagent). 
An Aminco-Bowman SPF fluorimeter was used. In 
fluoroimmunoassay experiments, excitation and 
25 
emission wavelengths were 495 nm and 540 nm, 50, , I I I, 
respectively. All fluorescence studies were performed 
in 0.075 M barbital buffer, pH 8.6. Fluorescein (sodium 
salt) was from Sigma. 
Sheep anti-T4 serum, previously characterised in an 
RIA system [5], was used. An antibody dilution 
curve was constructed by adding 0.75 ml aliquots of 
labelled T4 solution (9.9 pg/l) to doubling dilutions 
(1.25 ml) of anti-T4 serum. After 15 min incubation 
(room temperature) to allow for equilibration, the 
fluorescence intensity of each mixture was measured. 
The fluorescence background signal contributed by 
the diluted antiserum was separately measured in 
absence of labelled-T,+ and the fluorescence intensity 
of each incubation mixture corrected appropriately. 
The experiment was repeated using a normal sheep 
serum in place of the anti-T4 serum. 
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Fig.1. Antibody dilution curves. Closed symbols: anti-T, sewn 
open symbols: normal sheep serum. 
For the standard curve, T4 solutions of known 
concentration were prepared and to 0.5 ml aliquots 
were added 0.5 ml labelled-T4 solution (18.6 pg/l), 
followed by 0.5 ml of anti-T4 serum (diluted 1: 1000). 
After 15 min (room temperature) the fluorescence 
intensity of each assay mixture was measured. The 
background fluorescence signal of the diluted antiserum 
was measured and results corrected as above. 
of added T+ Unlabelled-T4 had no effect on the non- 
specific enhancement in presence of normal serum. A 
preparation of labelled-T4 which had been stored for 
15 months in frozen solution showed no evidence of 
deterioration when used in the fluoroimmunoassay 
system. 
4. Discussion 
3. Results 
Fluorescein-labelled T4 was reproducibly prepared 
in yield typically of 60% of the weight of starting 
products, and appeared at least 99% pure with respect 
to fluorescein and iodothyronine content by paper 
chromatography @values: FITC, 0.35; labelled Tq, 
0.25; Tq, 0.0). The fluorescence emission maximum 
(uncorrected) was 520 nm, compared with 5 17 nm 
for fluorescein itself. The fluorescence yield at 520 nm 
of the labelled-T4 was only 13% of that of fluorescein 
at the same wavelength. 
Fluorescein itself and the products of reaction of 
FIT% \;ith common amino acids are very efficient 
fluorophores in alkaline aqueous solution [6]. 
Fluorescein-labelled T4 represents an exception. This 
Figure 1 shows that the fluorescence of labelled T4 
is enhanced to a maximum extent of 3.9-fold upon 
binding by the anti-T4 serum. Some non-specific 
binding to the normal sheep serum is evident, but 
binding by the specific antiserum is complete at 13 10 30 loo 300 1000 
dilutions at which non-specific effects are negligible. FINAL THYROXINE CMJCMTRATION 
The standard curve (frg.2) shows that unlabelled T4 
InmoWlI 
competes for antiserum binding as indicated by decrease Fig.2. Enhancement fluoroimmunoassay of thyroxine: 
of observed fluorescence with increasing concentration standard curve. 
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observation is most likely attributable to intra-mole- 
cular quenching of the fluorescein fluorophore by the 
iodine atoms of the iodothyronine function of T4. 
Iodine-containing molecules are well recognised as 
efficient quenchers of fluorescence by either collisional 
[7] or external heavy atom [8] mechanisms. The 
marked enhancement of fluorescence upon binding to 
antiserum might then be understood in terms of 
inhibition of quenching when the iodothyronine 
moiety becomes bound within the combining site of 
specific anti-T4 antibody. 
The fluorescence enhancement effect provides the 
basis for a fluoroimmunoassay of T4 involving only 
the mixing of three reagents (sample, labelled-T4 and 
antiserum), followed after a short incubation by 
measurement of the fluorescence intensity of the 
labelled-T4. Compared with radioassay and RIA 
methods employing 1251-labelled T4 which are 
currently applied in evaluation of thyroid function 
[9], the technique has several attractions. Fluorescein- 
labelled T4 may be easily and safely prepared in any 
desired quantity from readily available materials, and 
has practically indefinite shelf-life. The assay end- 
point is determined by conventional fluorimetry. No 
seperation step is involved, which simplifies the proce- 
dure and should facilitate automation, notably of 
continuous-flow type. On the other hand, the fluoro- 
immunoassay is less sensitive than typical RIA methods 
for T4 by one to two orders of magnitude, and appre- 
ciable and variable levels of intrinsic serum fluorescence 
present an obstacle to assay of patient samples. However. 
given a reliable method for removal of such interference, 
enhancement fluoroimmunoassay might be expected 
to prove sufficiently sensitive for quantitation of total 
T4 levels in routine clinical monitoring of thyroid 
disorders. 
References 
111 
121 
131 
141 
151 
161 
171 
181 
191 
Scharpe, S. L., Cooreman, W. M., Blomme, W. J. and 
Laekeman, G. M. (1976) Clin. Chem. 22,733-738. 
Wisdom, G. B. (1976) Clin. Chem. 22, 1243-1255. 
Watson, R. A. A., Landon, J., Shaw, E. J. and Smith, D. S. 
(1976) Clin. Chim. Acta 73,51-‘55. 
Shaw, E. J., Watson, R. A. A., Landon, J. and Smith, D. S. 
(1977) J. Clin. Path., in press. 
Nye, L., Hassan, M., Willmott, E. and Landon, J. (1976) 
J. Clin. Path. 29,452-457. 
Kawauchi, H., Kadooka, K., Tanaka, M. and Tuzimura, K. 
(1971) Agr. Biol. Chem. 35,1720-1726. 
Ware, W. R. (1968) Surv. Prog. Chem. 4,205-270. 
Wehry, E. L. (1967) in: Fluorescence (Guilbault, G. G. ed) 
pp. 37-132, Arnold, Londen. 
Burke, C. W. and Eastman, C. J. (1974) Brit. Med. Bull. 
30,93-99. 
27 
